The next board meeting for Compass Therapeutics Inc is on 12 Nov 2025 for the purpose of Compass Therapeutics Inc Third Quarter Earnings Results for 2025See details
Compass Therapeutics Inc has a share price target of US$ 13, revenue growth forecast of 791.8%, and profit growth estimate of -55.1% for FY26, based on top 11 analyst calls.